β-Estradiol 17-acetate
Based on 1 publication(s) in Google Scholar
β-Estradiol 17-acetate (1,3,5(10)-Estratriene-3,17β-diol 17-acetate) is a long-acting endogenous estrogen precursor and also a cell viability and proliferation enhancer. β-Estradiol 17-acetate promotes the adhesion and proliferation of freshly isolated and revived female-derived human brain microvascular endothelial cells, and reverses the decreased viability of revived male-derived human brain microvascular endothelial cells. β-Estradiol 17-acetate exerts the microvascular protective effect of estrogen, enabling non-tumor human brain microvascular endothelial cells to be cultured in vitro for 2 months after cryopreservation. β-Estradiol 17-acetate is biotransformed into β-estradiol via hydrolase action in the in vitro skin of humans, hairless dogs, rats and hairless mice.
For research use only. We do not sell to patients.
- Purity: 99.88%
- CAS No.: 1743-60-8
- Formula: C20H26O3
- Molecular Weight:314.42
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
-
Bioactive Compound Library Max
HY-L181
-
Bioactive Compound Library
HY-L001
-
Natural Product Library
HY-L021
-
Lipid Compound Library
HY-L043
-
Endocrinology Compound Library
HY-L047
-
Phenols Library
HY-L057
-
Protein-protein Interaction Inhibitor Library
HY-L109
-
Nuclear Receptor Compound Library
HY-L126
-
Membrane Receptor-targeted Compound Library
HY-L150
-
Animal-Sourced Natural Product Library
HY-L157
-
MCE Bioactive Compound Library
HY-L001V
-
Natural Product Library Plus
HY-L021P
-
Natural Product and Natural Product-Like Compound Library
HY-L021M
-
RO5 Drug-like Natural Product Library
HY-L200
-
High-Throughput Bioactive Compound Library
HY-L205
-
High-Throughput Natural Product Library
HY-L206
-
Mass Spectrometry Natural Product Library
HY-L262
Publications Citing Use of MedChemExpress (MCE) β-Estradiol 17-acetate
More
Biological Activity
β-Estradiol 17-acetate (10 nM; 22 d) potently enhances the adhesion and proliferation capacities of hBMEC derived from postmenopausal female patients, and significantly increases the cell density of hBMEC derived from male patients[1].
β-Estradiol 17-acetate (10 nM; 33 d) maintains the viability and sustained proliferative capacity of hBMEC derived from postmenopausal female patients, whereas withdrawal of this hormone causes irreversible loss of cell adhesion and proliferative capacity[1].
β-Estradiol 17-acetate (10 nM; 32 d) restores the viability, adhesion and proliferation capacities of cryopreserved-thawed GM-derived hBMECs, and the adverse effects caused by hormone withdrawal are fully reversed upon re-administration of this substance[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1743-60-8
-
Appearance Solid
-
Molecular Weight 314.42
-
Formula C20H26O3
-
Color White to off-white
-
SMILES
C[C@@]1([C@H]2OC(C)=O)[C@](CC2)([H])[C@@](CCC3=C4C=CC(O)=C3)([H])[C@]4([H])CC1
-
Synonyms
1,3,5(10)-Estratriene-3,17β-diol 17-acetate
-
Structure Classification
-
Initial Source
the skin of various animal models
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Biomolecules
Active Estrogen-Succinate Metabolism Promotes Heme Accumulation and Increases the Proliferative and Invasive Potential of Endometrial Cancer Cells. [Abstract]2023 Jul 10;13(7):1097. PMID: 37509133
Solvent & Solubility
DMSO : 37.5 mg/mL (119.27 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 1.88 mg/mL (5.98 mM); Suspended solution
This protocol yields a suspended solution of ≥ 1.88 mg/mL (saturation unknown). Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (18.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 1.88 mg/mL (5.98 mM); Clear solution
This protocol yields a clear solution of ≥ 1.88 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (18.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (276 KB)
-
SDS (396 KB)
- English - EN (396 KB)
- Français - FR (396 KB)
- Deutsch - DE (396 KB)
- Norwegian - NO (396 KB)
- Español - ES (396 KB)
- Swedish - SV (396 KB)
- Italian - IT (396 KB)
- Korean - KR (396 KB)
- Portuguese - PT (396 KB)
-
Handling Instructions (2659 KB)
References
[1]. Guzzo S, et al. β-Estradiol 17-acetate enhances the in vitro vitality of endothelial cells isolated from the brain of patients subjected to neurosurgery. Neural Regen Res. 2023;18(2):389-395. [Content Brief]
[2]. Hikima T, et al. Comparison of skin distribution of hydrolytic activity for bioconversion of beta-estradiol 17-acetate between man and several animals in vitro. Eur J Pharm Biopharm. 2002;54(2):155-160. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.1805 mL | 15.9023 mL | 31.8046 mL | 79.5115 mL |
| 5 mM | 0.6361 mL | 3.1805 mL | 6.3609 mL | 15.9023 mL | |
| 10 mM | 0.3180 mL | 1.5902 mL | 3.1805 mL | 7.9511 mL | |
| 15 mM | 0.2120 mL | 1.0602 mL | 2.1203 mL | 5.3008 mL | |
| 20 mM | 0.1590 mL | 0.7951 mL | 1.5902 mL | 3.9756 mL | |
| 25 mM | 0.1272 mL | 0.6361 mL | 1.2722 mL | 3.1805 mL | |
| 30 mM | 0.1060 mL | 0.5301 mL | 1.0602 mL | 2.6504 mL | |
| 40 mM | 0.0795 mL | 0.3976 mL | 0.7951 mL | 1.9878 mL | |
| 50 mM | 0.0636 mL | 0.3180 mL | 0.6361 mL | 1.5902 mL | |
| 60 mM | 0.0530 mL | 0.2650 mL | 0.5301 mL | 1.3252 mL | |
| 80 mM | 0.0398 mL | 0.1988 mL | 0.3976 mL | 0.9939 mL | |
| 100 mM | 0.0318 mL | 0.1590 mL | 0.3180 mL | 0.7951 mL |
β-Estradiol 17-acetate Related Classifications
HY-B0708 Related Classifications
Powered by Bioz
- β-Estradiol 17-acetate
- 1743-60-8
- 1,3,5(10)-Estratriene-3,17β-diol 17-acetate
- Estrogen Receptor/ERR
- WM-derived hBMECs
- rat
- hairless mouse
- postmenopausal female patients
- human cadaver skin
- human brain microvascular endothelial cells
- male patients
- epidermal metabolic activity
- GM-derived hBMECs
- hairless dog
- Inhibitor
- inhibitor
- inhibit